Clinical Trials Browser

Phase 1/2 × Glioblastoma × Lead × Clear all

NCT03277638 2026-06-05

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Phase 1/2 Active not recruiting

Brain Neoplasms, Glioblastoma